DCM Shriram Limited — Q4 FY26
DCM Shriram reported Q4 FY26 revenue of ₹3,193 crore, up 11% YoY, driven by strong performance in chemicals (+32%), Fenesta (+34%), and farm solutions (+32%).
neutral
medium
✓ Verified against BSE filing
Indian management teams deliver on roughly 12% of specific earnings-call promises. A low score does not indicate dishonesty — it reflects how aspirational forward guidance typically is.
Q3 FY26
ECH plant full commissioning by Q4 end
Balance capacity of the epichlorohydrin plant to be commissioned by end of Q4 FY26, with stabilization expected thereafter.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1